Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by National Cancer Institute (NCI)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00565851
First received: November 29, 2007
Last updated: July 1, 2014
Last verified: February 2014
  Purpose

This randomized phase III trial is studying giving carboplatin, paclitaxel and gemcitabine together with or without bevacizumab after surgery to see how well it works in treating patients with recurrent ovarian epithelial cancer, primary peritoneal cavity cancer, or fallopian tube cancer. Drugs used in chemotherapy, such as carboplatin, paclitaxel and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known whether combination chemotherapy is more effective when given with or without bevacizumab after surgery in treating patients with recurrent ovarian epithelial cancer, primary peritoneal cavity cancer, or fallopian tube cancer.


Condition Intervention Phase
Brenner Tumor
Fallopian Tube Cancer
Ovarian Clear Cell Cystadenocarcinoma
Ovarian Endometrioid Adenocarcinoma
Ovarian Mixed Epithelial Carcinoma
Ovarian Mucinous Cystadenocarcinoma
Ovarian Serous Cystadenocarcinoma
Ovarian Undifferentiated Adenocarcinoma
Primary Peritoneal Cavity Cancer
Recurrent Ovarian Epithelial Cancer
Drug: paclitaxel
Drug: docetaxel
Drug: carboplatin
Biological: bevacizumab
Drug: gemcitabine hydrochloride
Other: laboratory biomarker analysis
Other: quality-of-life assessment
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)

Resource links provided by NLM:


Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Overall survival [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Progression-free survival [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]
  • Frequency and severity of adverse events assessed by Common Terminology Criteria for Adverse Events version 3.0 [ Time Frame: Up to 10 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 660
Study Start Date: December 2007
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Arm I (paclitaxel, docetaxel, carboplatin)
Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days.
Drug: paclitaxel
Given IV
Other Names:
  • Anzatax
  • Asotax
  • TAX
  • Taxol
Drug: docetaxel
Given IV
Other Names:
  • RP 56976
  • Taxotere
  • TXT
Drug: carboplatin
Given IV
Other Names:
  • Carboplat
  • CBDCA
  • JM-8
  • Paraplat
  • Paraplatin
Other: laboratory biomarker analysis
Correlative studies
Other: quality-of-life assessment
Ancillary studies
Other Name: quality of life assessment
Experimental: Arm II (paclitaxel, docetaxel, carboplatin, bevacizumab)
Patients receive chemotherapy as in arm I and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days.
Drug: paclitaxel
Given IV
Other Names:
  • Anzatax
  • Asotax
  • TAX
  • Taxol
Drug: docetaxel
Given IV
Other Names:
  • RP 56976
  • Taxotere
  • TXT
Drug: carboplatin
Given IV
Other Names:
  • Carboplat
  • CBDCA
  • JM-8
  • Paraplat
  • Paraplatin
Biological: bevacizumab
Given IV
Other Names:
  • anti-VEGF humanized monoclonal antibody
  • anti-VEGF monoclonal antibody
  • Avastin
  • rhuMAb VEGF
Other: laboratory biomarker analysis
Correlative studies
Other: quality-of-life assessment
Ancillary studies
Other Name: quality of life assessment
Experimental: Arm III (gemcitabine, carboplatin)
Patients receive gemcitabine IV over 60 minutes on days 1and 8 and carboplatin as in arm I.
Drug: carboplatin
Given IV
Other Names:
  • Carboplat
  • CBDCA
  • JM-8
  • Paraplat
  • Paraplatin
Drug: gemcitabine hydrochloride
Given IV
Other Names:
  • dFdC
  • difluorodeoxycytidine hydrochloride
  • gemcitabine
  • Gemzar
Other: laboratory biomarker analysis
Correlative studies
Other: quality-of-life assessment
Ancillary studies
Other Name: quality of life assessment
Experimental: Arm IV (gemcitabine, bevacizumab, carboplatin)
Patients receive gemcitabine IV as in arm III, bevacizumab IV and carboplatin IV as in arm II.
Drug: carboplatin
Given IV
Other Names:
  • Carboplat
  • CBDCA
  • JM-8
  • Paraplat
  • Paraplatin
Biological: bevacizumab
Given IV
Other Names:
  • anti-VEGF humanized monoclonal antibody
  • anti-VEGF monoclonal antibody
  • Avastin
  • rhuMAb VEGF
Drug: gemcitabine hydrochloride
Given IV
Other Names:
  • dFdC
  • difluorodeoxycytidine hydrochloride
  • gemcitabine
  • Gemzar
Other: laboratory biomarker analysis
Correlative studies
Other: quality-of-life assessment
Ancillary studies
Other Name: quality of life assessment

  Hide Detailed Description

Detailed Description:

PRIMARY OBJECTIVES:

I. To determine if surgical secondary cytoreduction in addition to adjuvant chemotherapy increases the duration of overall survival in patients with recurrent platinum sensitive epithelial ovarian cancer, peritoneal primary or fallopian tube cancer.

II. To determine if the addition of bevacizumab to the second-line and maintenance phases of treatment increases the duration of overall survival relative to second-line paclitaxel and carboplatin alone in patients with recurrent platinum sensitive epithelial ovarian cancer, peritoneal primary or fallopian tube cancer.

SECOND OBJECTIVES:

I. To determine if the addition of bevacizumab to the second-line and maintenance phase of treatment increases the duration of progression-free survival relative to second-line paclitaxel and carboplatin alone in patients with recurrent platinum sensitive epithelial ovarian cancer, peritoneal primary or Fallopian tube cancer.

II. To prospectively determine the incidence of carboplatin and paclitaxel hypersensitivity in these patients undergoing retreatment with both agents as first recurrence therapy.

III. To determine if surgical secondary cytoreduction in addition to adjuvant chemotherapy increases quality of life (QOL) of patients with recurrent platinum-sensitive ovarian epithelial cancer or primary peritoneal cavity cancer, as measured by the Functional Assessment of Cancer Therapy (FACT)-O trial outcome index and Rand SF-36 physical functioning scale.

IV. To determine if the addition of bevacizumab to the second-line and maintenance phases of treatment increases QOL relative to second-line paclitaxel and carboplatin alone in patients with recurrent platinum-sensitive ovarian epithelial cancer or primary peritoneal cavity cancer.

OUTLINE: This is a multicenter study. Patients are assigned to 1 of 4 treatment groups. Patients who are not candidates for surgical cytoreduction (i.e., those for whom complete cytoreduction in the estimation of the investigator is impossible or a medical infirmity precludes exploration and debulking) are eligible to receive chemotherapy after randomization.

Patients who are eligible for surgery undergo abdominal exploration with cytoreduction and undergo tumor tissue collection and complete a quality of life questionnaire before and after surgery. All patients are then randomized to 1 of 4 treatment arms.

ARM I: Patients receive paclitaxel intravenously (IV) over 3 hours or docetaxel IV over 1 hour and carboplatin IV over 60 minutes on day 1.

ARM II: Patients receive chemotherapy as in arm I and bevacizumab IV over 30-90 minutes on day 1.

ARM III: Patients receive gemcitabine IV over 60 minutes on days 1and 8 and carboplatin as in arm I.

ARM IV: Patients receive gemcitabine IV as in arm III, bevacizumab IV and carboplatin IV as in arm II.

In all arms, treatment repeats every 21 days in the absence of disease progression or unacceptable toxicity.

Patients with measurable disease achieving a clinical response (CR) receive 6-8 courses of therapy. Patients with stable disease or partial regression receive a maximum of 6 courses.

Patients without measurable lesions as determined by a computed tomography (CT) scan prior to initiating study treatment continue therapy for 6 courses or, if CA-125 normalizes, for 2 cycles beyond CA-125 normalization, whichever is greater. Patients in arm II then receive a maintenance regimen comprising bevacizumab IV over 30-90 minutes. Treatment with bevacizumab alone repeats every 3 weeks in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed periodically for 10 years.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients must have histologic diagnosis of ovarian epithelial carcinoma, peritoneal primary or fallopian tube carcinoma, which is now recurrent
  • The following histologic epithelial cell types are eligible:

    • Serous adenocarcinoma
    • Endometrioid adenocarcinoma
    • Mucinous adenocarcinoma
    • Undifferentiated carcinoma
    • Clear cell adenocarcinoma
    • Mixed epithelial carcinoma
    • Transitional cell carcinoma
    • Malignant Brenner Tumor
    • Adenocarcinoma not otherwise specified
  • Patients must have had a complete response to front-line platinum-taxane therapy (at least 3 cycles) and a treatment-free interval without clinical evidence of progressive disease lasting at least 6 months

    • A complete response to front-line chemotherapy must include the following:

      • Negative physical exam
      • Negative pelvic exam
      • Normalization of CA125, if elevated at baseline
      • Negative radiographic assessment of disease
    • All patients must have also had a treatment-free interval without clinical evidence of progressive disease of at least 6 months from completion of front-line chemotherapy (both platinum and taxane); front-line therapy may have included a biologic agent
    • Front-line treatment may include maintenance therapy following complete clinical or pathological response; however, maintenance cytotoxic chemotherapy must be discontinued for a minimum of 6 months prior to documentation of recurrent disease; patients receiving maintenance biological therapy or hormonal therapy are ELIGIBLE provided their recurrence is documented more than 6 months from primary cytotoxic chemotherapy completion (includes maintenance chemotherapy) AND a minimum 4 weeks has elapsed since their last infusion of biological therapy
  • Patients must have clinically evident recurrent disease for the purpose of this study,

    • Measurable disease (RECIST) is defined as at least one lesion that can be accurately measured in at least one dimension (longest dimension to be recorded); each lesion must be more than or equal to 20 mm when measured by conventional techniques, MRI or CT, or more than or equal to 10 mm when measured by spiral CT
  • Absolute neutrophil count (ANC) >= 1,500/mm^3 equivalent to Common Toxicity Criteria for Adverse Events v3.0 (CTCAE) Grade1
  • Platelet count >= 100,000/mm^3 (Common Terminology Criteria for Adverse Events [CTCAE] Grade 0-1)
  • Creatinine (non-isotope dilution mass spectrometry [IDMS]) =< 1.5 times upper limit of normal (ULN)
  • Total bilirubin =< 1.5 times ULN
  • Serum glutamic oxaloacetic transaminase (SGOT)/aspartate aminotransferase (AST) =< 2.5 times ULN (< 5.0 times ULN in the presence of liver metastasis)
  • Alkaline phosphatase =< 2.5 times ULN (< 5.0 times ULN in the presence of liver metastasis)
  • Patients must have a urine protein-to-creatinine ratio (UPCR) < 1.0 mg/dL
  • Patients who are not candidates for surgical cytoreduction are eligible for the chemotherapy randomization; patients are not considered candidates for surgical cytoreduction if complete cytoreduction in the estimation of the investigator is impossible or a medical infirmity precludes exploration and debulking
  • Patients must have signed an approved informed consent and authorization permitting release of personal health information
  • Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Exclusion Criteria:

  • Patients who have more than one previous regimen of chemotherapy (maintenance therapy is not considered a second regimen)
  • Patients receiving concurrent immunotherapy, or radiotherapy
  • Patients who have received prior radiotherapy to any portion of the abdominal cavity or pelvis are excluded
  • Patients whom have already undergone secondary cytoreduction for recurrent disease are excluded
  • Patients with a prior histologic diagnosis of borderline, low malignant potential (grade 0) epithelial carcinoma that was surgically resected and who subsequently developed an unrelated, new invasive epithelial ovarian or peritoneal primary cancer are eligible provided they meet the inclusion criteria above
  • Patients who require parenteral hydration or nutrition and have evidence of partial bowel obstruction or perforation
  • Patients with synchronous primary endometrial cancer, or a past history of primary endometrial cancer are excluded, unless all of the following conditions are met:

    • Stage not greater than I-B;
    • No more than superficial myometrial invasion, without vascular or lymphatic invasion;
    • No poorly differentiated subtypes, including papillary serous, clear cell or other International Federation of Gynecology and Obstetrics (FIGO) Grade 3 lesions
  • Patients with uncontrolled infection
  • Patients with concurrent severe medical problems unrelated to the malignancy that would significantly limit full compliance with the study or expose the patient to extreme risk or decreased life expectancy
  • Patients with peripheral neuropathy >= grade 2
  • Patients with a history of allergic reactions to carboplatin and/or paclitaxel or chemically similar compounds; patients with allergic (hypersensitivity) reactions to these chemotherapeutic agents are NOT excluded IF they were successfully retreated following a desensitization program or protocol
  • Patients with known hypersensitivity to Chinese hamster ovary cell products or other recombinant human or humanized antibodies
  • Patients of childbearing potential, not practicing adequate contraception, patients who are pregnant or patients who are nursing are not eligible for this trial; to date, no fetal studies in animal or humans have been performed; the possibility of harm to a fetus is likely; bevacizumab specifically inhibits VEGF, which is responsible for the formation of new blood vessels during development, and antibodies can cross the placenta; therefore, bevacizumab should not be administered to pregnant women; in addition, there are unknown immediate and long-term consequences of chemotherapy administration to these women; in addition, surgical exploration as mandated by randomization during pregnancy may cause imminent mortal consequences; further, it is not known whether bevacizumab is excreted in human milk; because many drugs are excreted in human milk, bevacizumab should not be administered to nursing women; subjects will be apprised of the large potential risk to a developing fetus
  • Patients with other invasive malignancies, with the exception of nonmelanoma skin cancer, or patients who had (or have) any evidence of the other cancer present within the past 5 years or whose previous cancer treatment contraindicates this protocol therapy
  • Patients with active bleeding or pathologic conditions that carry high risk of bleeding such as a known bleeding disorder, coagulopathy, or tumor involving major vessels
  • Patients with a history or evidence upon physical examination of central nervous system (CNS) disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases, or a history of stroke within the past 5 years of the first date of treatment on this study
  • Patients with clinically significant cardiovascular disease including any of the following:

    • Significant cardiac conduction abnormalities (e.g., PR interval > 0.24 sec or 2nd or 3rd degree atrioventricular [AV] block )
    • Uncontrolled hypertension, defined as systolic blood pressure (BP) > 150 mm Hg or diastolic BP > 90 mm Hg
    • Myocardial infarction, cardiac arrhythmia, or unstable angina within the past 6 months
    • New York Heart Association (NYHA) grade II or greater congestive heart failure
    • Serious cardiac arrhythmia requiring medication
    • Grade II or greater peripheral vascular disease except episodes of ischemia < 24 hrs in duration that are managed non-surgically and without permanent deficit
    • History of cerebrovascular accident (CVA) within the past 6 months
  • Patients who have had a major surgical procedure, open biopsy, dental extractions or other dental surgery/procedure that results in an open wound, or significant traumatic injury within 28 days prior to the first date of treatment on this study, or anticipation of need for major surgical procedure during the course of the study; patients with placement of vascular access device or core biopsy within 7 days prior to the first date of treatment on this study:

    • Patients undergoing pre-treatment secondary cytoreduction will undergo therapy with bevacizumab on cycle 2
    • Patients undergoing pre-treatment surgery for purposes other than cytoreduction may also participate provided they meet eligibility; patients randomized to arms containing bevacizumab must wait a minimum of 28 days since that procedure to begin protocol treatment; patients who undergo an uncomplicated port placement must wait a minimum of 7 days to begin protocol treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00565851

  Hide Study Locations
Locations
United States, Alaska
Alaska Breast Care and Surgery LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Alaska Women's Cancer Care Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Anchorage Oncology Centre Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Katmai Oncology Group Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Providence Alaska Medical Center Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
United States, Arizona
Gynecologic Oncology Group of Arizona Recruiting
Phoenix, Arizona, United States, 85012
Contact: Robert L. Coleman    713-792-3245    rcoleman@mdanderson.org   
Principal Investigator: Robert L. Coleman         
United States, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center Withdrawn
Burbank, California, United States, 91505
John Muir Medical Center-Concord Campus Withdrawn
Concord, California, United States, 94520
Long Beach Memorial Medical Center-Todd Cancer Institute Recruiting
Long Beach, California, United States, 90806
Contact: Robert E. Bristow    562-933-0900    ucstudy@uci.edu   
Principal Investigator: Robert E. Bristow         
Kaiser Permanente Los Angeles Medical Center Recruiting
Los Angeles, California, United States, 90027
Contact: Scott E. Lentz    626-564-3455      
Principal Investigator: Scott E. Lentz         
Kaiser Permanente Medical Care Program - Los Angeles Medical Center &amp; Sunset Hospital Recruiting
Los Angeles, California, United States, 90027
Contact: Scott E. Lentz    626-564-3455      
Principal Investigator: Scott E. Lentz         
Jonsson Comprehensive Cancer Center Recruiting
Los Angeles, California, United States, 90095
Contact: Robin Farias-Eisner    888-798-0719      
Principal Investigator: Robin Farias-Eisner         
Palo Alto Medical Foundation-Gynecologic Oncology Recruiting
Mountain View, California, United States, 94040
Contact: Albert L. Pisani    650-934-7000      
Principal Investigator: Albert L. Pisani         
University of California Medical Center At Irvine-Orange Campus Recruiting
Orange, California, United States, 92868
Contact: Krishnansu S. Tewari    714-456-6191    awallick@uci.edu   
Principal Investigator: Krishnansu S. Tewari         
UCSF-Mount Zion Recruiting
San Francisco, California, United States, 94115
Contact: Lee-May Chen    877-827-3222      
Principal Investigator: Lee-May Chen         
Stanford University Hospitals and Clinics Active, not recruiting
Stanford, California, United States, 94305
John Muir Medical Center Withdrawn
Walnut Creek, California, United States, 94598
United States, Colorado
University of Colorado Cancer Center - Anschutz Cancer Pavilion Recruiting
Aurora, Colorado, United States, 80045
Contact: Susan A. Davidson    720-848-0650      
Principal Investigator: Susan A. Davidson         
The Medical Center of Aurora Recruiting
Aurora, Colorado, United States, 80012
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Boulder Recruiting
Boulder, Colorado, United States, 80304
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Boulder Community Hospital Recruiting
Boulder, Colorado, United States, 80301
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Penrose-Saint Francis Healthcare Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Penrose Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Exempla Saint Joseph Hospital Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Rose Recruiting
Denver, Colorado, United States, 80220
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Porter Adventist Hospital Recruiting
Denver, Colorado, United States, 80210
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Midtown Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Colorado Cancer Research Program CCOP Recruiting
Denver, Colorado, United States, 80224-2522
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rose Medical Center Recruiting
Denver, Colorado, United States, 80220
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Colorado Blood Cancer Institute Recruiting
Denver, Colorado, United States, 80907
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Presbyterian - Saint Lukes Medical Center - Health One Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Mercy Medical Center Recruiting
Durango, Colorado, United States, 81301
Contact: Cynthia K. Cathcart    888-785-6789      
Principal Investigator: Cynthia K. Cathcart         
Swedish Medical Center Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Comprehensive Cancer Care and Research Institute of Colorado LLC Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Gynecologic Oncology PC Terminated
Englewood, Colorado, United States, 80110
Mountain Blue Cancer Care Center Recruiting
Golden, Colorado, United States, 80401
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Saint Mary's Hospital and Regional Medical Center Terminated
Grand Junction, Colorado, United States, 81502
North Colorado Medical Center Recruiting
Greeley, Colorado, United States, 80631
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Breast Cancer Care Consultants Recruiting
Greenwood Village, Colorado, United States, 80111
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Lakewood Recruiting
Lakewood, Colorado, United States, 80228
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Saint Anthony Hospital Recruiting
Lakewood, Colorado, United States, 80228
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Littleton Adventist Hospital Recruiting
Littleton, Colorado, United States, 80122
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Sky Ridge Medical Center Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Sky Ridge Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Longmont Recruiting
Longmont, Colorado, United States, 80501
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Longmont United Hospital Recruiting
Longmont, Colorado, United States, 80501
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
McKee Medical Center Recruiting
Loveland, Colorado, United States, 80539
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Parker Recruiting
Parker, Colorado, United States, 80138
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Parker Adventist Hospital Recruiting
Parker, Colorado, United States, 80138
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Saint Mary Corwin Medical Center Recruiting
Pueblo, Colorado, United States, 81004
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers - Pueblo Recruiting
Pueblo, Colorado, United States, 81008
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
North Suburban Medical Center Terminated
Thornton, Colorado, United States, 80229
Exempla Lutheran Medical Center Recruiting
Wheat Ridge, Colorado, United States, 80033
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
United States, Connecticut
University of Connecticut Recruiting
Farmington, Connecticut, United States, 06030
Contact: Angela S. Kueck    800-579-7822      
Principal Investigator: Angela S. Kueck         
Hartford Hospital Recruiting
Hartford, Connecticut, United States, 06102
Contact: James S. Hoffman    860-224-5660      
Principal Investigator: James S. Hoffman         
Saint Francis Hospital and Medical Center Recruiting
Hartford, Connecticut, United States, 06105
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Middlesex Hospital Recruiting
Middletown, Connecticut, United States, 06457
Contact: Jonathan A. Cosin    860-224-5660      
Principal Investigator: Jonathan A. Cosin         
The Hospital of Central Connecticut Recruiting
New Britain, Connecticut, United States, 06050
Contact: James S. Hoffman    860-224-5660      
Principal Investigator: James S. Hoffman         
United States, Delaware
Beebe Medical Center Recruiting
Lewes, Delaware, United States, 19958
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Christiana Care Health System-Christiana Hospital Recruiting
Newark, Delaware, United States, 19718
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Christiana Gynecologic Oncology LLC Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Delaware Clinical and Laboratory Physicians PA Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Helen F Graham Cancer Center Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Medical Oncology Hematology Consultants PA Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Regional Hematology and Oncology PA Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Beebe Health Campus Recruiting
Rehoboth Beach, Delaware, United States, 19971
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Christiana Care Health System-Wilmington Hospital Recruiting
Wilmington, Delaware, United States, 19801
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
United States, District of Columbia
Washington Hospital Center Active, not recruiting
Washington, District of Columbia, United States, 20010
United States, Florida
Florida Gynecologic Oncology Recruiting
Fort Myers, Florida, United States, 33905
Contact: Edward C. Grendys    800-874-7502      
Principal Investigator: Edward C. Grendys         
Florida Hospital Recruiting
Orlando, Florida, United States, 32803
Contact: James E. Kendrick    407-303-5623      
Principal Investigator: James E. Kendrick         
Women's Cancer Associates Active, not recruiting
Saint Petersburg, Florida, United States, 33701
United States, Georgia
Georgia Regents University Recruiting
Augusta, Georgia, United States, 30912
Contact: Sharad A. Ghamande    706-721-1663    cancer@georgiahealth.edu   
Principal Investigator: Sharad A. Ghamande         
John B Amos Cancer Center Recruiting
Columbus, Georgia, United States, 31904
Contact: Gregory P. Sfakianos    706-660-6404      
Principal Investigator: Gregory P. Sfakianos         
Northeast Georgia Medical Center Recruiting
Gainesville, Georgia, United States, 30501
Contact: Andrew E. Green    770-219-8800    cancerpatient.navigator@nghs.com   
Principal Investigator: Andrew E. Green         
Saint Joseph's-Candler Health System Recruiting
Savannah, Georgia, United States, 31405
Contact: William E. Richards    800-622-6877    uchealthnews@uc.edu   
Principal Investigator: William E. Richards         
Memorial Health University Medical Center Recruiting
Savannah, Georgia, United States, 31403
Contact: James J. Burke    912-350-8568      
Principal Investigator: James J. Burke         
United States, Idaho
Saint Alphonsus Regional Medical Center Recruiting
Boise, Idaho, United States, 83706
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
United States, Illinois
Rush - Copley Medical Center Recruiting
Aurora, Illinois, United States, 60504
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
University of Illinois Active, not recruiting
Chicago, Illinois, United States, 60612
University of Chicago Recruiting
Chicago, Illinois, United States, 60637
Contact: Meaghan E. Tenney    773-834-7424    julie-traylor@ouhsc.edu   
Principal Investigator: Meaghan E. Tenney         
Rush University Medical Center Active, not recruiting
Chicago, Illinois, United States, 60612
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Julian C. Schink    616-391-3050    cancer@northwestern.edu   
Principal Investigator: Julian C. Schink         
Carle on Vermilion Recruiting
Danville, Illinois, United States, 61832
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Carle Physician Group-Effingham Recruiting
Effingham, Illinois, United States, 62401
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Sudarshan K Sharma MD Limted-Gynecologic Oncology Recruiting
Hinsdale, Illinois, United States, 60521
Contact: Sudarshan K. Sharma    630-856-6757      
Principal Investigator: Sudarshan K. Sharma         
Carle Physician Group-Mattoon/Charleston Recruiting
Mattoon, Illinois, United States, 61938
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Good Samaritan Regional Health Center Active, not recruiting
Mount Vernon, Illinois, United States, 62864
Memorial Medical Center Active, not recruiting
Springfield, Illinois, United States, 62781-0001
Carle Cancer Center Recruiting
Urbana, Illinois, United States, 61801
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
The Carle Foundation Hospital Recruiting
Urbana, Illinois, United States, 61801
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Rush-Copley Healthcare Center Recruiting
Yorkville, Illinois, United States, 60560
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
United States, Indiana
Michiana Hematology Oncology PC-Elkhart Recruiting
Elkhart, Indiana, United States, 46514
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Elkhart Clinic Recruiting
Elkhart, Indiana, United States, 46514-2098
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Elkhart General Hospital Recruiting
Elkhart, Indiana, United States, 46515
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Indiana University Medical Center Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Jeanne M. Schilder    317-274-2552      
Principal Investigator: Jeanne M. Schilder         
Saint Vincent Hospital and Health Services Active, not recruiting
Indianapolis, Indiana, United States, 46260
Saint Vincent Oncology Center Withdrawn
Indianapolis, Indiana, United States, 46260
Community Howard Regional Health Recruiting
Kokomo, Indiana, United States, 46904
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
IU Health La Porte Hospital Recruiting
La Porte, Indiana, United States, 46350
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Franciscan Saint Anthony Health-Michigan City Recruiting
Michigan City, Indiana, United States, 46360
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Woodland Cancer Care Center Recruiting
Michigan City, Indiana, United States, 46360
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Saint Joseph Regional Medical Center-Mishawaka Recruiting
Mishawaka, Indiana, United States, 46545-1470
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Michiana Hematology Oncology PC-Mishawaka Recruiting
Mishawaka, Indiana, United States, 46545-1470
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
The Community Hospital Recruiting
Munster, Indiana, United States, 46321
Contact: Mohamad Kassar    219-836-3349      
Principal Investigator: Mohamad Kassar         
Michiana Hematology Oncology PC-Plymouth Recruiting
Plymouth, Indiana, United States, 46563
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Reid Hospital and Health Care Services Recruiting
Richmond, Indiana, United States, 47374
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Michiana Hematology Oncology PC-South Bend Recruiting
South Bend, Indiana, United States, 46601
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
South Bend Clinic Recruiting
South Bend, Indiana, United States, 46617
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Northern Indiana Cancer Research Consortium Recruiting
South Bend, Indiana, United States, 46628
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Memorial Hospital of South Bend Terminated
South Bend, Indiana, United States, 46601
Michiana Hematology Oncology-PC Westville Recruiting
Westville, Indiana, United States, 46391
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
United States, Iowa
Medical Oncology and Hematology Associates-West Des Moines Recruiting
Clive, Iowa, United States, 50325
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Mercy Cancer Center-West Lakes Recruiting
Clive, Iowa, United States, 50325
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Iowa Methodist Medical Center Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Iowa Lutheran Hospital Recruiting
Des Moines, Iowa, United States, 50316
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Des Moines Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Laurel Recruiting
Des Moines, Iowa, United States, 50314
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Iowa Oncology Research Association CCOP Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Mercy Medical Center - Des Moines Recruiting
Des Moines, Iowa, United States, 50314
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
University of Iowa Hospitals and Clinics Recruiting
Iowa City, Iowa, United States, 52242
Contact: David P. Bender    800-237-1225      
Principal Investigator: David P. Bender         
Abben Cancer Center Withdrawn
Spencer, Iowa, United States, 51301
Mercy Medical Center-West Lakes Recruiting
West Des Moines, Iowa, United States, 50266
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
Methodist West Hospital Recruiting
West Des Moines, Iowa, United States, 50266-7700
Contact: Robert J. Behrens    888-244-6061    sherrijr@iora.org   
Principal Investigator: Robert J. Behrens         
United States, Kansas
Cancer Center of Kansas - Chanute Recruiting
Chanute, Kansas, United States, 66720
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Dodge City Recruiting
Dodge City, Kansas, United States, 67801
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - El Dorado Recruiting
El Dorado, Kansas, United States, 67042
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Fort Scott Recruiting
Fort Scott, Kansas, United States, 66701
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Independence Recruiting
Independence, Kansas, United States, 67301
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Providence Medical Center Terminated
Kansas City, Kansas, United States, 66112
Cancer Center of Kansas-Kingman Recruiting
Kingman, Kansas, United States, 67068
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Lawrence Memorial Hospital Recruiting
Lawrence, Kansas, United States, 66044
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Liberal Recruiting
Liberal, Kansas, United States, 67901
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Manhattan Recruiting
Manhattan, Kansas, United States, 66502
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - McPherson Recruiting
McPherson, Kansas, United States, 67460
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Newton Recruiting
Newton, Kansas, United States, 67114
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Saint Luke's South Hospital Active, not recruiting
Overland Park, Kansas, United States, 66213
Cancer Center of Kansas - Parsons Recruiting
Parsons, Kansas, United States, 67357
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Kansas City CCOP Active, not recruiting
Prairie Village, Kansas, United States, 66208
Cancer Center of Kansas - Pratt Recruiting
Pratt, Kansas, United States, 67124
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Salina Recruiting
Salina, Kansas, United States, 67401
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Wellington Recruiting
Wellington, Kansas, United States, 67152
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Wichita Medical Arts Tower Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Wesley Medical Center Active, not recruiting
Wichita, Kansas, United States, 67214
Wichita CCOP Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Associates In Womens Health Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Via Christi Regional Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Main Office Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Winfield Recruiting
Winfield, Kansas, United States, 67156
Contact: Shaker R. Dakhil    316-262-4467      
Principal Investigator: Shaker R. Dakhil         
United States, Kentucky
Oncology Hematology Care Incorporated Recruiting
Crestview Hills, Kentucky, United States, 41017
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
The James Graham Brown Cancer Center at University of Louisville Recruiting
Louisville, Kentucky, United States, 40202
Contact: Lynn P. Parker    866-530-5516      
Principal Investigator: Lynn P. Parker         
United States, Louisiana
Hematology/Oncology Clinic LLP Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: William R. Robinson    504-988-6121      
Principal Investigator: William R. Robinson         
Woman's Hospital Withdrawn
Baton Rouge, Louisiana, United States, 70817
Tulane University Health Sciences Center Recruiting
New Orleans, Louisiana, United States, 70112
Contact: William R. Robinson    504-988-6121      
Principal Investigator: William R. Robinson         
United States, Maryland
Franklin Square Hospital Center Active, not recruiting
Baltimore, Maryland, United States, 21237
Greater Baltimore Medical Center Recruiting
Baltimore, Maryland, United States, 21204
Contact: Amanda N. Fader    410-955-8804    jhcccro@jhmi.edu   
Principal Investigator: Amanda N. Fader         
Sinai Hospital of Baltimore Recruiting
Baltimore, Maryland, United States, 21215
Contact: Fouad M. Abbas    410-601-6120    pridgely@lifebridgehealth.org   
Principal Investigator: Fouad M. Abbas         
Walter Reed National Military Medical Center Recruiting
Bethesda, Maryland, United States, 20889-5600
Contact: Michael P. Stany    301-319-2100      
Principal Investigator: Michael P. Stany         
Union Hospital of Cecil County Terminated
Elkton MD, Maryland, United States, 21921
United States, Massachusetts
University of Massachusetts Memorial Health Care Recruiting
Worcester, Massachusetts, United States, 01605
Contact: Susan L. Zweizig    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: Susan L. Zweizig         
United States, Michigan
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106-0995
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
University of Michigan Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Carolyn M. Johnston    734-712-3456      
Principal Investigator: Carolyn M. Johnston         
Michigan Cancer Research Consortium Community Clinical Oncology Program Recruiting
Ann Arbor, Michigan, United States, 48106
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Bronson Battle Creek Recruiting
Battle Creek, Michigan, United States, 49017
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Spectrum Health Big Rapids Hospital Recruiting
Big Rapids, Michigan, United States, 49307
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Oakwood Hospital Recruiting
Dearborn, Michigan, United States, 48124
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Henry Ford Hospital Recruiting
Detroit, Michigan, United States, 48202
Contact: Thomas E. Buekers    313-916-1784      
Principal Investigator: Thomas E. Buekers         
Saint John Hospital and Medical Center Recruiting
Detroit, Michigan, United States, 48236
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Wayne State University/Karmanos Cancer Institute Recruiting
Detroit, Michigan, United States, 48201
Contact: Robert T. Morris    313-576-9363      
Principal Investigator: Robert T. Morris         
Green Bay Oncology - Escanaba Recruiting
Escanaba, Michigan, United States, 49431
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Hurley Medical Center Recruiting
Flint, Michigan, United States, 48502
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Genesys Regional Medical Center Terminated
Grand Blanc, Michigan, United States, 48439
Gynecologic Oncology of West Michigan PLLC Active, not recruiting
Grand Rapids, Michigan, United States, 49546
Mercy Health Saint Mary's Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Grand Rapids Clinical Oncology Program Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Spectrum Health at Butterworth Campus Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Green Bay Oncology - Iron Mountain Recruiting
Iron Mountain, Michigan, United States, 49801
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Allegiance Health Recruiting
Jackson, Michigan, United States, 49201
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Bronson Methodist Hospital Active, not recruiting
Kalamazoo, Michigan, United States, 49007
West Michigan Cancer Center Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Raymond S. Lord    269-373-7458      
Principal Investigator: Raymond S. Lord         
Borgess Medical Center Active, not recruiting
Kalamazoo, Michigan, United States, 49001
Sparrow Hospital Recruiting
Lansing, Michigan, United States, 48912
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Saint Mary Mercy Hospital Recruiting
Livonia, Michigan, United States, 48154
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Mercy Health Partners-Hackley Campus Terminated
Muskegon, Michigan, United States, 49442
Mercy Health Mercy Campus Recruiting
Muskegon, Michigan, United States, 49444
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Lakeland Community Hospital Recruiting
Niles, Michigan, United States, 49120
Contact: Michael Rodriguez    574-237-1328      
Principal Investigator: Michael Rodriguez         
Michiana Hematology Oncology PC-Niles Terminated
Niles, Michigan, United States, 49120
Northern Michigan Regional Hospital Active, not recruiting
Petoskey, Michigan, United States, 49770
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341-2985
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Port Huron Recruiting
Port Huron, Michigan, United States, 48060
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Spectrum Health Reed City Hospital Recruiting
Reed City, Michigan, United States, 49677
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
William Beaumont Hospital-Royal Oak Active, not recruiting
Royal Oak, Michigan, United States, 48073
Saint Mary's of Michigan Recruiting
Saginaw, Michigan, United States, 48601
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Marie Yeager Cancer Center Terminated
Saint Joseph, Michigan, United States, 49085
Lakeland Hospital Terminated
St. Joseph, Michigan, United States, 49085
Munson Medical Center Recruiting
Traverse City, Michigan, United States, 49684
Contact: Gilbert D. Padula    616-685-5225      
Principal Investigator: Gilbert D. Padula         
Saint John Macomb-Oakland Hospital Recruiting
Warren, Michigan, United States, 48093
Contact: Philip J. Stella    734-712-3456      
Principal Investigator: Philip J. Stella         
Metro Health Hospital Terminated
Wyoming, Michigan, United States, 49519
United States, Minnesota
Sanford Clinic North-Bemidgi Recruiting
Bemidji, Minnesota, United States, 56601
Contact: Maria C. Bell    218-333-5000      
Principal Investigator: Maria C. Bell         
Fairview Ridges Hospital Recruiting
Burnsville, Minnesota, United States, 55337
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Mercy Hospital Recruiting
Coon Rapids, Minnesota, United States, 55433
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Saint Luke's Hospital of Duluth Withdrawn
Duluth, Minnesota, United States, 55805
Fairview-Southdale Hospital Recruiting
Edina, Minnesota, United States, 55435
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Unity Hospital Recruiting
Fridley, Minnesota, United States, 55432
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Hutchinson Area Health Care Recruiting
Hutchinson, Minnesota, United States, 55350
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Minnesota Oncology Hematology PA-Maplewood Recruiting
Maplewood, Minnesota, United States, 55109
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Saint John's Hospital - Healtheast Recruiting
Maplewood, Minnesota, United States, 55109
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Abbott-Northwestern Hospital Recruiting
Minneapolis, Minnesota, United States, 55407
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
New Ulm Medical Center Recruiting
New Ulm, Minnesota, United States, 56073
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
North Memorial Medical Health Center Recruiting
Robbinsdale, Minnesota, United States, 55422
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Metro-Minnesota CCOP Recruiting
Saint Louis Park, Minnesota, United States, 55416
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Park Nicollet Clinic - Saint Louis Park Recruiting
Saint Louis Park, Minnesota, United States, 55416
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
United Hospital Recruiting
Saint Paul, Minnesota, United States, 55102
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Regions Hospital Recruiting
Saint Paul, Minnesota, United States, 55101
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Saint Francis Regional Medical Center Recruiting
Shakopee, Minnesota, United States, 55379
Contact: Patrick J. Flynn    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Patrick J. Flynn         
Lakeview Hospital Recruiting
Stillwater, Minnesota, United States, 55082
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Ridgeview Medical Center Recruiting
Waconia, Minnesota, United States, 55387
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Rice Memorial Hospital Recruiting
Willmar, Minnesota, United States, 56201
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
Minnesota Oncology and Hematology PA-Woodbury Recruiting
Woodbury, Minnesota, United States, 55125
Contact: Matthew P. Boente    952-993-1517    MMCCOP@parknicollet.com   
Principal Investigator: Matthew P. Boente         
United States, Mississippi
Saint Dominic-Jackson Memorial Hospital Recruiting
Jackson, Mississippi, United States, 39216
Contact: Donald P. Seago    601-200-3300      
Principal Investigator: Donald P. Seago         
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: James T. Thigpen    601-815-6700      
Principal Investigator: James T. Thigpen         
Singing River Hospital Recruiting
Pascagoula, Mississippi, United States, 39581
Contact: James E. Clarkson    228-809-5292      
Principal Investigator: James E. Clarkson         
United States, Missouri
Central Care Cancer Center-Carrie J Babb Cancer Center Active, not recruiting
Bolivar, Missouri, United States, 65613
CoxHealth Cancer Center Active, not recruiting
Branson, Missouri, United States, 65616
University of Missouri - Ellis Fischel Recruiting
Columbia, Missouri, United States, 65212
Contact: Mark I. Hunter    573-882-7440      
Principal Investigator: Mark I. Hunter         
Freeman Health System Active, not recruiting
Joplin, Missouri, United States, 64804
Mercy Hospital-Joplin Active, not recruiting
Joplin, Missouri, United States, 64804
Saint Luke's Hospital of Kansas City Active, not recruiting
Kansas City, Missouri, United States, 64111
Saint Luke's Cancer Institute Terminated
Kansas City, Missouri, United States, 64111
Research Medical Center Active, not recruiting
Kansas City, Missouri, United States, 64132
Saint Luke's East - Lee's Summit Active, not recruiting
Lee's Summit, Missouri, United States, 64086
Liberty Hospital Recruiting
Liberty, Missouri, United States, 64068
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Phelps County Regional Medical Center Active, not recruiting
Rolla, Missouri, United States, 65401
Saint John's Clinic-Rolla-Cancer and Hematology Active, not recruiting
Rolla, Missouri, United States, 65401
Saint John's Mercy Medical Center Active, not recruiting
Saint Louis, Missouri, United States, 63141
Saint Louis University Hospital Active, not recruiting
Saint Louis, Missouri, United States, 63110
Missouri Baptist Medical Center Active, not recruiting
Saint Louis, Missouri, United States, 63131
Saint Louis Cancer and Breast Institute-South City Active, not recruiting
Saint Louis, Missouri, United States, 63109
Washington University School of Medicine Active, not recruiting
Saint Louis, Missouri, United States, 63110
Ozark Health Ventures LLC-Cancer Research for The Ozarks Springfield Active, not recruiting
Springfield, Missouri, United States, 65804
Mercy Hospital Springfield Active, not recruiting
Springfield, Missouri, United States, 65804
CoxHealth South Hospital Active, not recruiting
Springfield, Missouri, United States, 65807
United States, Nebraska
Nebraska Methodist Hospital Recruiting
Omaha, Nebraska, United States, 68114
Contact: Peter C. Morris    402-354-7939    kathryn.bartz@nmhs.org   
Principal Investigator: Peter C. Morris         
United States, Nevada
Women's Cancer Center of Nevada Recruiting
Las Vegas, Nevada, United States, 89169
Contact: Nicola M. Spirtos    702-851-4672      
Principal Investigator: Nicola M. Spirtos         
Renown Regional Medical Center Recruiting
Reno, Nevada, United States, 89502
Contact: Peter C. Lim    866-513-8227      
Principal Investigator: Peter C. Lim         
Center of Hope at Renown Medical Center Recruiting
Reno, Nevada, United States, 89502
Contact: Peter C. Lim    866-513-8227      
Principal Investigator: Peter C. Lim         
United States, New Jersey
Cooper Hospital University Medical Center Recruiting
Camden, New Jersey, United States, 08103
Contact: David P. Warshal    856-325-6757      
Principal Investigator: David P. Warshal         
Cancer Institute of New Jersey At Hamilton Active, not recruiting
Hamilton, New Jersey, United States, 08690
Morristown Memorial Hospital Recruiting
Morristown, New Jersey, United States, 07962
Contact: Daniel H. Tobias    973-971-5900      
Principal Investigator: Daniel H. Tobias         
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Recruiting
Mount Holly, New Jersey, United States, 08060
Contact: Randolph B. Deger    888-847-8823      
Principal Investigator: Randolph B. Deger         
Jersey Shore Medical Center Active, not recruiting
Neptune, New Jersey, United States, 07753
Rutgers Cancer Institute of New Jersey Terminated
New Brunswick, New Jersey, United States, 08903
The Women's Institute for Gynecologic Cancer and Special Pelvic Surgery Recruiting
Phillipsburg, New Jersey, United States, 08865
Contact: David F. Silver    718-765-2500      
Principal Investigator: David F. Silver         
Overlook Hospital Recruiting
Summit, New Jersey, United States, 07902
Contact: Daniel H. Tobias    973-971-5900      
Principal Investigator: Daniel H. Tobias         
MD Anderson Cancer Center at Cooper-Voorhees Recruiting
Voorhees, New Jersey, United States, 08043
Contact: David P. Warshal    856-325-6757      
Principal Investigator: David P. Warshal         
Virtua West Jersey Hospital Voorhees Recruiting
Voorhees, New Jersey, United States, 08043
Contact: Randolph B. Deger    888-847-8823      
Principal Investigator: Randolph B. Deger         
United States, New Mexico
University of New Mexico Cancer Center Recruiting
Albuquerque, New Mexico, United States, 87106
Contact: Carolyn Y. Muller    505-272-6972      
Principal Investigator: Carolyn Y. Muller         
Southwest Gynecologic Oncology Associates Inc Recruiting
Albuquerque, New Mexico, United States, 87106
Contact: Carolyn Y. Muller    505-272-6972      
Principal Investigator: Carolyn Y. Muller         
Memorial Medical Center - Las Cruces Recruiting
Las Cruces, New Mexico, United States, 88011
Contact: Carolyn Y. Muller    505-272-6972      
Principal Investigator: Carolyn Y. Muller         
United States, New York
Women's Cancer Care Associates LLC Recruiting
Albany, New York, United States, 12208
Contact: Thomas P. Morrissey    518-458-1390      
Principal Investigator: Thomas P. Morrissey         
Island Gynecologic Oncology Recruiting
Brightwaters, New York, United States, 11718
Contact: Benjamin M. Schwartz    631-376-0055ext107      
Principal Investigator: Benjamin M. Schwartz         
State University of New York Downstate Medical Center Recruiting
Brooklyn, New York, United States, 11203
Contact: Ovadia Abulafia    718-270-8216    sima.terebelo@downstate.edu   
Principal Investigator: Ovadia Abulafia         
Roswell Park Cancer Institute Recruiting
Buffalo, New York, United States, 14263
Contact: Shashikant B. Lele    877-275-7724      
Principal Investigator: Shashikant B. Lele         
North Shore University Hospital Active, not recruiting
Manhasset, New York, United States, 11030
North Shore-LIJ Health System/Center for Advanced Medicine Active, not recruiting
New Hyde Park, New York, United States, 11040
Long Island Jewish Medical Center Active, not recruiting
New Hyde Park, New York, United States, 11040
Memorial Sloan-Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Mario M. Leitao    212-639-7202      
Principal Investigator: Mario M. Leitao         
Mount Sinai Medical Center Recruiting
New York, New York, United States, 10029
Contact: Jamal Rahaman    212-824-7320    jenny.figueroa@mssm.edu   
Principal Investigator: Jamal Rahaman         
New York University Langone Medical Center Recruiting
New York, New York, United States, 10016
Contact: Stephanie V. Blank    212-263-4434    prmc.coordinator@nyumc.org   
Principal Investigator: Stephanie V. Blank         
Columbia University Medical Center Active, not recruiting
New York, New York, United States, 10032
Stony Brook University Medical Center Recruiting
Stony Brook, New York, United States, 11794
Contact: Michael L. Pearl    800-862-2215      
Principal Investigator: Michael L. Pearl         
State University of New York Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Contact: Mary J. Cunningham    315-464-5476      
Principal Investigator: Mary J. Cunningham         
United States, North Carolina
Randolph Hospital Recruiting
Asheboro, North Carolina, United States, 27203
Contact: James M. Granfortuna    336-832-0821      
Principal Investigator: James M. Granfortuna         
Cone Health Alamance Regional Medical Center Recruiting
Burlington, North Carolina, United States, 27216
Contact: Janak K. Choksi    336-538-7725      
Principal Investigator: Janak K. Choksi         
University of North Carolina Active, not recruiting
Chapel Hill, North Carolina, United States, 27599
Novant Health Presbyterian Medical Center Recruiting
Charlotte, North Carolina, United States, 28204
Contact: John M. McDonald    704-384-5369      
Principal Investigator: John M. McDonald         
Carolinas Medical Center Recruiting
Charlotte, North Carolina, United States, 28203
Contact: Robert V. Higgins    704-355-2884      
Principal Investigator: Robert V. Higgins         
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Contact: Angeles A. Secord    888-275-3853      
Principal Investigator: Angeles A. Secord         
Cone Health Cancer Center Recruiting
Greensboro, North Carolina, United States, 27403
Contact: James M. Granfortuna    336-832-0821      
Principal Investigator: James M. Granfortuna         
Duke Raleigh Hospital Active, not recruiting
Raleigh, North Carolina, United States, 27609
Annie Penn Memorial Hospital Recruiting
Reidsville, North Carolina, United States, 27320
Contact: James M. Granfortuna    336-832-0821      
Principal Investigator: James M. Granfortuna         
Wake Forest University Health Sciences Recruiting
Winston-Salem, North Carolina, United States, 27157
Contact: Samuel S. Lentz    336-713-6771      
Principal Investigator: Samuel S. Lentz         
United States, North Dakota
Sanford Bismarck Medical Center Active, not recruiting
Bismarck, North Dakota, United States, 58501
Roger Maris Cancer Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Maria C. Bell    218-333-5000      
Principal Investigator: Maria C. Bell         
Sanford Clinic North-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Maria C. Bell    218-333-5000      
Principal Investigator: Maria C. Bell         
Sanford Medical Center-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Maria C. Bell    218-333-5000      
Principal Investigator: Maria C. Bell         
United States, Ohio
Akron General Medical Center Withdrawn
Akron, Ohio, United States, 44307
Summa Akron City Hospital/Cooper Cancer Center Recruiting
Akron, Ohio, United States, 44304
Contact: Vivian E. von Gruenigen    330-375-6101      
Principal Investigator: Vivian E. von Gruenigen         
Strecker Cancer Center-Belpre Recruiting
Belpre, Ohio, United States, 45714
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Aultman Health Foundation Recruiting
Canton, Ohio, United States, 44710
Contact: Michael P. Hopkins    330-363-6891      
Principal Investigator: Michael P. Hopkins         
Adena Regional Medical Center Recruiting
Chillicothe, Ohio, United States, 45601
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Oncology Hematology Care Inc - Anderson Recruiting
Cincinnati, Ohio, United States, 45230
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
University of Cincinnati Recruiting
Cincinnati, Ohio, United States, 45267
Contact: Thomas J. Reid    937-298-3399    uchealthnews@uc.edu   
Principal Investigator: Thomas J. Reid         
Oncology and Hematology Care Incorporated Recruiting
Cincinnati, Ohio, United States, 45219
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Oncology and Hematology Care Inc - Blue Ash Recruiting
Cincinnati, Ohio, United States, 45242
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Oncology Hematology Care Inc - Western Hills Recruiting
Cincinnati, Ohio, United States, 45248
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Oncology Hematology Care Inc - Kenwood Recruiting
Cincinnati, Ohio, United States, 45236
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
MetroHealth Medical Center Active, not recruiting
Cleveland, Ohio, United States, 44109
Cleveland Clinic Cancer Center/Fairview Hospital Recruiting
Cleveland, Ohio, United States, 44111
Contact: Peter G. Rose    866-223-8100      
Principal Investigator: Peter G. Rose         
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Contact: Steven E. Waggoner    800-641-2422      
Principal Investigator: Steven E. Waggoner         
Cleveland Clinic Foundation Recruiting
Cleveland, Ohio, United States, 44195
Contact: Peter G. Rose    866-223-8100      
Principal Investigator: Peter G. Rose         
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting
Columbus, Ohio, United States, 43210
Contact: David M. O'Malley    866-627-7616    osu@emergingmed.com   
Principal Investigator: David M. O'Malley         
Doctors Hospital Recruiting
Columbus, Ohio, United States, 43228
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Columbus CCOP Recruiting
Columbus, Ohio, United States, 43215
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
The Mark H Zangmeister Center Recruiting
Columbus, Ohio, United States, 43219
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Grant Medical Center Recruiting
Columbus, Ohio, United States, 43215
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Riverside Methodist Hospital Recruiting
Columbus, Ohio, United States, 43214
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Mount Carmel Health Center West Recruiting
Columbus, Ohio, United States, 43222
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Grandview Hospital Recruiting
Dayton, Ohio, United States, 45405
Contact: Thomas J. Reid    937-298-3399    uchealthnews@uc.edu   
Principal Investigator: Thomas J. Reid         
Samaritan North Health Center Recruiting
Dayton, Ohio, United States, 45415
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Dayton CCOP Recruiting
Dayton, Ohio, United States, 45420
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Good Samaritan Hospital - Dayton Recruiting
Dayton, Ohio, United States, 45406
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Miami Valley Hospital Recruiting
Dayton, Ohio, United States, 45409
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Delaware Health Center-Grady Cancer Center Recruiting
Delaware, Ohio, United States, 43015
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Delaware Radiation Oncology Recruiting
Delaware, Ohio, United States, 43015
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Grady Memorial Hospital Recruiting
Delaware, Ohio, United States, 43015
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Oncology Hematology Care Inc Recruiting
Fairfield, Ohio, United States, 45014
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Blanchard Valley Hospital Recruiting
Findlay, Ohio, United States, 45840
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Atrium Medical Center-Middletown Regional Hospital Recruiting
Franklin, Ohio, United States, 45005-1066
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Wayne Hospital Recruiting
Greenville, Ohio, United States, 45331
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Kettering Medical Center Recruiting
Kettering, Ohio, United States, 45429
Contact: Thomas J. Reid    937-298-3399    uchealthnews@uc.edu   
Principal Investigator: Thomas J. Reid         
Lancaster Radiation Oncology Recruiting
Lancaster, Ohio, United States, 43130
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Fairfield Medical Center Recruiting
Lancaster, Ohio, United States, 43130
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Marietta Memorial Hospital Recruiting
Marietta, Ohio, United States, 45750
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Hillcrest Hospital Cancer Center Recruiting
Mayfield Heights, Ohio, United States, 44124
Contact: Peter G. Rose    866-223-8100      
Principal Investigator: Peter G. Rose         
Lake University Ireland Cancer Center Recruiting
Mentor, Ohio, United States, 44060
Contact: Steven E. Waggoner    800-641-2422      
Principal Investigator: Steven E. Waggoner         
Knox Community Hospital Recruiting
Mount Vernon, Ohio, United States, 43050
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Newark Radiation Oncology Recruiting
Newark, Ohio, United States, 43055
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Southern Ohio Medical Center Recruiting
Portsmouth, Ohio, United States, 45662
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Springfield Regional Medical Center Recruiting
Springfield, Ohio, United States, 45505
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Upper Valley Medical Center Recruiting
Troy, Ohio, United States, 45373
Contact: Howard M. Gross    765-983-3000      
Principal Investigator: Howard M. Gross         
Saint Ann's Hospital Recruiting
Westerville, Ohio, United States, 43081
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Genesis HealthCare System Recruiting
Zanesville, Ohio, United States, 43701
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
United States, Oklahoma
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Robert S. Mannel    405-271-4272    julie-traylor@ouhsc.edu   
Principal Investigator: Robert S. Mannel         
Oklahoma Oncology Inc Recruiting
Tulsa, Oklahoma, United States, 74104
Contact: David G. McIntosh    601-815-6700      
Principal Investigator: David G. McIntosh         
Natalie Warren Bryant Cancer Center at Saint Francis Recruiting
Tulsa, Oklahoma, United States, 74136
Contact: David G. McIntosh    601-815-6700      
Principal Investigator: David G. McIntosh         
Tulsa Cancer Institute Recruiting
Tulsa, Oklahoma, United States, 74146
Contact: Robert S. Mannel    405-271-4272    julie-traylor@ouhsc.edu   
Principal Investigator: Robert S. Mannel         
Warren Cancer Research Foundation Recruiting
Tulsa, Oklahoma, United States, 74136
Contact: David G. McIntosh    601-815-6700      
Principal Investigator: David G. McIntosh         
Warren Clinic-Tulsa South Recruiting
Tulsa, Oklahoma, United States, 74136
Contact: David G. McIntosh    601-815-6700      
Principal Investigator: David G. McIntosh         
United States, Oregon
Clackamas Radiation Oncology Center Recruiting
Clackamas, Oregon, United States, 97015
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Providence Milwaukie Hospital Recruiting
Milwaukie, Oregon, United States, 97222
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Providence Newberg Medical Center Recruiting
Newberg, Oregon, United States, 97132
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Providence Willamette Falls Medical Center Recruiting
Oregon City, Oregon, United States, 97045
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Legacy Good Samaritan Hospital and Medical Center Recruiting
Portland, Oregon, United States, 97210
Contact: William E. Winter    503-280-1223      
Principal Investigator: William E. Winter         
Compass Oncology Rose Quarter Terminated
Portland, Oregon, United States, 97227
Providence Portland Medical Center Recruiting
Portland, Oregon, United States, 97213
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Oregon Health and Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Tanja Pejovic    503-494-1080    trials@ohsu.edu   
Principal Investigator: Tanja Pejovic         
Providence Saint Vincent Medical Center Recruiting
Portland, Oregon, United States, 97225
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Western Oncology Research Consortium Recruiting
Portland, Oregon, United States, 97213
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
United States, Pennsylvania
Abington Memorial Hospital Recruiting
Abington, Pennsylvania, United States, 19001
Contact: Parviz Hanjani    215-481-2402      
Principal Investigator: Parviz Hanjani         
Lehigh Valley Hospital Recruiting
Allentown, Pennsylvania, United States, 18105
Contact: Alyson F. McIntosh    610-402-2273      
Principal Investigator: Alyson F. McIntosh         
Saint Luke's University Hospital-Bethlehem Campus Active, not recruiting
Bethlehem, Pennsylvania, United States, 18015
Lehigh Valley Hospital - Muhlenberg Recruiting
Bethlehem, Pennsylvania, United States, 18017
Contact: Alyson F. McIntosh    610-402-2273      
Principal Investigator: Alyson F. McIntosh         
Geisinger Medical Center Recruiting
Danville, Pennsylvania, United States, 17822-2001
Contact: James R. Bosscher    570-271-5251    ehicks@sprg.mercy.net   
Principal Investigator: James R. Bosscher         
Geisinger Medical Center-Cancer Center Hazleton Recruiting
Hazleton, Pennsylvania, United States, 18201
Contact: James R. Bosscher    570-271-5251    ehicks@sprg.mercy.net   
Principal Investigator: James R. Bosscher         
Penn State Milton S Hershey Medical Center Active, not recruiting
Hershey, Pennsylvania, United States, 17033-0850
University of Pennsylvania/Abramson Cancer Center Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Robert A. Burger    215-746-7406      
Principal Investigator: Robert A. Burger         
Pennsylvania Hospital Active, not recruiting
Philadelphia, Pennsylvania, United States, 19107
Gynecologic Oncology Group Recruiting
Philadelphia, Pennsylvania, United States, 19103
Contact: Robert L. Coleman    713-745-3357    rcoleman@mdanderson.org   
Principal Investigator: Robert L. Coleman         
Temple University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19140
Contact: Enrique Hernandez    215-728-2983      
Principal Investigator: Enrique Hernandez         
Fox Chase Cancer Center Active, not recruiting
Philadelphia, Pennsylvania, United States, 19111
Geisinger Medical Group Recruiting
State College, Pennsylvania, United States, 16801
Contact: James R. Bosscher    570-271-5251    ehicks@sprg.mercy.net   
Principal Investigator: James R. Bosscher         
Reading Hospital Recruiting
West Reading, Pennsylvania, United States, 19611
Contact: Bernice L. Robinson-Bennett    610-988-9323      
Principal Investigator: Bernice L. Robinson-Bennett         
Geisinger Wyoming Valley Recruiting
Wilkes-Barre, Pennsylvania, United States, 18711
Contact: James R. Bosscher    570-271-5251    ehicks@sprg.mercy.net   
Principal Investigator: James R. Bosscher         
United States, Rhode Island
Women and Infants Hospital Recruiting
Providence, Rhode Island, United States, 02905
Contact: Paul A. DiSilvestro    401-274-1122      
Principal Investigator: Paul A. DiSilvestro         
United States, South Carolina
Medical University of South Carolina Active, not recruiting
Charleston, South Carolina, United States, 29425
United States, South Dakota
Black Hills Obstetrics and Gynecology Recruiting
Rapid City, South Dakota, United States, 57701
Contact: Helen L. Frederickson    605-343-9224      
Principal Investigator: Helen L. Frederickson         
Avera Cancer Institute Recruiting
Sioux Falls, South Dakota, United States, 57105
Contact: Luis A. Rojas-Espaillat    800-657-4377    Jan.Healy@avera.org   
Principal Investigator: Luis A. Rojas-Espaillat         
Sanford Cancer Center-Oncology Clinic Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: Maria C. Bell    218-333-5000      
Principal Investigator: Maria C. Bell         
Sanford USD Medical Center - Sioux Falls Recruiting
Sioux Falls, South Dakota, United States, 57117-5134
Contact: Maria C. Bell    218-333-5000      
Principal Investigator: Maria C. Bell         
United States, Tennessee
Wellmont Bristol Regional Medical Center Recruiting
Bristol, Tennessee, United States, 37620
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Wellmont Medical Associates Oncology and Hematology-Johnson City Recruiting
Johnson City, Tennessee, United States, 37604
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Wellmont Holston Valley Hospital and Medical Center Recruiting
Kingsport, Tennessee, United States, 37660
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Wellmont Medical Associates Oncology and Hematology-Kingsport Recruiting
Kingsport, Tennessee, United States, 37660
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
United States, Texas
The Don and Sybil Harrington Cancer Center Active, not recruiting
Amarillo, Texas, United States, 79106
University Medical Center Brackenridge Recruiting
Austin, Texas, United States, 78701
Contact: Mark A. Crozier    512-324-7991      
Principal Investigator: Mark A. Crozier         
University of Texas Southwestern Medical Center Recruiting
Dallas, Texas, United States, 75390
Contact: David S. Miller    214-648-7097      
Principal Investigator: David S. Miller         
Parkland Memorial Hospital Recruiting
Dallas, Texas, United States, 75235
Contact: David S. Miller    214-648-7097      
Principal Investigator: David S. Miller         
Brooke Army Medical Center Active, not recruiting
Fort Sam Houston, Texas, United States, 78234
University of Texas Medical Branch at Galveston Recruiting
Galveston, Texas, United States, 77555-0565
Contact: Lyuba Levine    409-772-1950    clinical.research@utmb.edu   
Principal Investigator: Lyuba Levine         
Memorial Hermann Texas Medical Center Recruiting
Houston, Texas, United States, 77030
Contact: Joseph A. Lucci    866-574-5124    Sylvester@emergingmed.com   
Principal Investigator: Joseph A. Lucci         
M D Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Robert L. Coleman    713-792-3245      
Principal Investigator: Robert L. Coleman         
Methodist Hospital Recruiting
Houston, Texas, United States, 77030
Contact: Aparna A. Kamat    713-790-2700      
Principal Investigator: Aparna A. Kamat         
M D Anderson Cancer Center Active, not recruiting
Houston, Texas, United States, 77030
United States, Utah
McKay-Dee Hospital Center Recruiting
Ogden, Utah, United States, 84403
Contact: Ross E. Morgan    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Ross E. Morgan         
Utah Valley Regional Medical Center Recruiting
Provo, Utah, United States, 84604-3337
Contact: Ross E. Morgan    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Ross E. Morgan         
Dixie Medical Center Regional Cancer Center Recruiting
Saint George, Utah, United States, 84770
Contact: Ross E. Morgan    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Ross E. Morgan         
LDS Hospital Recruiting
Salt Lake City, Utah, United States, 84143
Contact: Ross E. Morgan    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Ross E. Morgan         
Huntsman Cancer Institute/University of Utah Recruiting
Salt Lake City, Utah, United States, 84112
Contact: Theresa L. Werner    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Theresa L. Werner         
United States, Vermont
Fletcher Allen Health Care-Medical Center Recruiting
Burlington, Vermont, United States, 05401
Contact: Cheung Wong    802-656-8990      
Principal Investigator: Cheung Wong         
United States, Virginia
University of Virginia Recruiting
Charlottesville, Virginia, United States, 22908
Contact: Susan C. Modesitt    434-243-6143      
Principal Investigator: Susan C. Modesitt         
Southwest VA Regional Cancer Center Recruiting
Norton, Virginia, United States, 24273
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Virginia Commonwealth University Recruiting
Richmond, Virginia, United States, 23298
Contact: Weldon E. Chafe    804-628-1939      
Principal Investigator: Weldon E. Chafe         
Carilion Clinic Gynecological Oncology Recruiting
Roanoke, Virginia, United States, 24016
Contact: Janet L. Osborne    540-985-8510      
Principal Investigator: Janet L. Osborne         
United States, Washington
PeaceHealth Medical Group PC Recruiting
Bellingham, Washington, United States, 98226
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Harrison HealthPartners Hematology and Oncology-Bremerton Terminated
Bremerton, Washington, United States, 98310
Harrison Medical Center Terminated
Bremerton, Washington, United States, 98310
Providence Regional Cancer Partnership Recruiting
Everett, Washington, United States, 98201
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Skagit Valley Hospital Regional Cancer Care Center Recruiting
Mount Vernon, Washington, United States, 98273
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Harrison HealthPartners Hematology and Oncology-Poulsbo Terminated
Poulsbo, Washington, United States, 98370
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Recruiting
Seattle, Washington, United States, 98109
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Northwest Hospital Recruiting
Seattle, Washington, United States, 98133
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Swedish Medical Center-First Hill Recruiting
Seattle, Washington, United States, 98122-4307
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Seattle Cancer Care Alliance Recruiting
Seattle, Washington, United States, 98109
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Group Health Cooperative-Seattle Terminated
Seattle, Washington, United States, 98112
University of Washington Medical Center Recruiting
Seattle, Washington, United States, 98195
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Pacific Gynecology Specialists Recruiting
Seattle, Washington, United States, 98104
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Virginia Mason CCOP Recruiting
Seattle, Washington, United States, 98101
Contact: Amy D. Brockmeyer    800-354-9527      
Principal Investigator: Amy D. Brockmeyer         
Olympic Medical Cancer Care Center Recruiting
Sequim, Washington, United States, 98384
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Cancer Care Northwest - Spokane South Recruiting
Spokane, Washington, United States, 99202
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Rockwood Cancer Treatment Center-Downtown Terminated
Spokane, Washington, United States, 99204
Saint Joseph Medical Center Recruiting
Tacoma, Washington, United States, 98405
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
Northwest Medical Specialties PLLC Active, not recruiting
Tacoma, Washington, United States, 98405
Tacoma General Hospital Terminated
Tacoma, Washington, United States, 98405
PeaceHealth Southwest Medical Center Recruiting
Vancouver, Washington, United States, 98664
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Compass Oncology Vancouver Recruiting
Vancouver, Washington, United States, 98684
Contact: Alison K. Conlin    503-215-6412      
Principal Investigator: Alison K. Conlin         
Providence Saint Mary Regional Cancer Center Terminated
Walla Walla, Washington, United States, 99362
Wenatchee Valley Medical Center Recruiting
Wenatchee, Washington, United States, 98801
Contact: Benjamin E. Greer    206-616-8289      
Principal Investigator: Benjamin E. Greer         
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Active, not recruiting
Yakima, Washington, United States, 98902
Cancer Institutes of Washington PLLC Terminated
Yakima, Washington, United States, 98902
United States, Wisconsin
Aurora Cancer Care-Grafton Recruiting
Grafton, Wisconsin, United States, 53024
Contact: Peter R. Johnson    414-649-5717      
Principal Investigator: Peter R. Johnson         
Aurora BayCare Medical Center Recruiting
Green Bay, Wisconsin, United States, 54311-6519
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Saint Mary's Hospital Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Green Bay Oncology Limited at Saint Mary's Hospital Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Green Bay Oncology at Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301-3526
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Gundersen Lutheran Recruiting
La Crosse, Wisconsin, United States, 54601
Contact: Sigurdur Bodvarsson    608-775-2385    cancerctr@gundluth.org   
Principal Investigator: Sigurdur Bodvarsson         
University of Wisconsin Hospital and Clinics Recruiting
Madison, Wisconsin, United States, 53792
Contact: David M. Kushner    877-405-6866      
Principal Investigator: David M. Kushner         
Bay Area Medical Center Recruiting
Marinette, Wisconsin, United States, 54143
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Vince Lombardi Cancer Clinic-Marinette Recruiting
Marinette, Wisconsin, United States, 54143
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Aurora Saint Luke's Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53215
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Aurora Sinai Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53233
Contact: Peter R. Johnson    414-649-5717      
Principal Investigator: Peter R. Johnson         
Froedtert and the Medical College of Wisconsin Recruiting
Milwaukee, Wisconsin, United States, 53226
Contact: William H. Bradley    414-805-4380      
Principal Investigator: William H. Bradley         
Cancer Center of Western Wisconsin Active, not recruiting
New Richmond, Wisconsin, United States, 54017
Green Bay Oncology - Oconto Falls Recruiting
Oconto Falls, Wisconsin, United States, 54154
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Vince Lombardi Cancer Clinic - Oshkosh Recruiting
Oshkosh, Wisconsin, United States, 54904
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Vince Lombardi Cancer Clinic-Sheboygan Recruiting
Sheboygan, Wisconsin, United States, 53081
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Green Bay Oncology - Sturgeon Bay Recruiting
Sturgeon Bay, Wisconsin, United States, 54235
Contact: Jonathan E. Tammela    920-433-8889      
Principal Investigator: Jonathan E. Tammela         
Aurora Medical Center in Summit Recruiting
Summit, Wisconsin, United States, 53066
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Vince Lombardi Cancer Clinic Recruiting
Two Rivers, Wisconsin, United States, 54241
Contact: Ali Mahdavi    414-649-5717    ucstudy@uci.edu   
Principal Investigator: Ali Mahdavi         
Aspirus Regional Cancer Center Withdrawn
Wausau, Wisconsin, United States, 54401
Aurora West Allis Medical Center Recruiting
West Allis, Wisconsin, United States, 53227
Contact: Peter R. Johnson    414-649-5717      
Principal Investigator: Peter R. Johnson         
Japan
Tohoku University School of Medicine Recruiting
Sendai, Aoba-ku, Japan, 980-8574
Contact: Nobuo Yaegashi       med-som@bureau.tohoku.ac.jp   
Principal Investigator: Nobuo Yaegashi         
Kure National Hospital Recruiting
Kure, Hiroshima, Japan, 737
Contact: Kazuhiro Takehara    089-999-1172      
Principal Investigator: Kazuhiro Takehara         
Hokkaido University Hospital Recruiting
Sapporo, Hokkaido, Japan, 060-8648
Contact: Noriaki Sakuragi       hassi@med.hokudai.ac.jp   
Principal Investigator: Noriaki Sakuragi         
Iwate Medical University School of Medicine Recruiting
Morioka, Iwate, Japan, 020-8505
Contact: Toru Sugiyama    019-651-5111      
Principal Investigator: Toru Sugiyama         
Niigata University Medical and Dental Hospital Recruiting
Niigata City, Niigata, Japan, 951-8520
Contact: Takayuki Enomoto    81-025-223-6161      
Principal Investigator: Takayuki Enomoto         
Shizuoka Cancer Center Recruiting
Shizuoka City, Suntou, Japan, 411-8777
Contact: Munetaka Takekuma    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Munetaka Takekuma         
Keio University Recruiting
Shinjuku-ku, Tokyo, Japan, 160-8582
Contact: Daisuke Aoki    03 5363-3848      
Principal Investigator: Daisuke Aoki         
Hiroshima University Hospital Recruiting
Hiroshima City, Japan, 734-8551
Contact: Eiji Hirata    82-424-6042      
Principal Investigator: Eiji Hirata         
Kagoshima City Hospital Recruiting
Kagoshima City, Kagoshima, Japan, 892-8580
Contact: Masayuki Hatae    011 81 099 224 2101      
Principal Investigator: Masayuki Hatae         
Shikoku Cancer Center Recruiting
Matsuyama, Japan, 791-0280
Contact: Takayoshi Nogawa    089-999-1172      
Principal Investigator: Takayoshi Nogawa         
National Kyushu Cancer Center Active, not recruiting
Minami-ku, Japan, 811 1395
Jikei University School of Medicine Active, not recruiting
Minato-ku, Tokyo, Japan, 105-8461
Kinki University Recruiting
Osaka, Osaka, Japan, 589 8511
Contact: Masaki Mandai    072-366-0221      
Principal Investigator: Masaki Mandai         
Saitama Medical University International Medical Center Active, not recruiting
Saitama, Japan, 350-1298
National Cancer Center Hospital Recruiting
Tokyo, Japan, 104 0045
Contact: Mayu Yunokawa    81-3-3542-2511    www-admin@ncc.go.jp   
Principal Investigator: Mayu Yunokawa         
Tottori University Active, not recruiting
Tottori, Japan, 680-8550
Korea, Republic of
Keimyung University-Dongsan Medical Center Recruiting
Jung-Ku, Daegu, Korea, Republic of, 700-712
Contact: Chi-Heum Cho       ho@dsmc.or.kr   
Principal Investigator: Chi-Heum Cho         
National Cancer Center-Korea Recruiting
Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769
Contact: Sang Y. Park    011-82-760-2384      
Principal Investigator: Sang Y. Park         
Catholic University of Korea-Seoul Saint Mary's Hospital Recruiting
Seoul, Korea, Korea, Republic of, 137-040
Contact: Keun H. Lee    2258-5745-6      
Principal Investigator: Keun H. Lee         
Samsung Medical Center Recruiting
Seoul, Korea, Korea, Republic of, 135-710
Contact: Duk-Soo Bae    011-82-1599-3114      
Principal Investigator: Duk-Soo Bae         
Seoul National University Bundang Hospital Recruiting
Seongnam City, Kyeonggi-do, Korea, Republic of, 463-707
Contact: Yong Beom Kim    011-82-760-2384      
Principal Investigator: Yong Beom Kim         
Korea Cancer Center Hospital Recruiting
Seoul, Korea, Republic of, 139-706
Contact: Moon-Hong Kim    011-82-02-9702-114      
Principal Investigator: Moon-Hong Kim         
Seoul National University Hospital Recruiting
Seoul, Korea, Republic of, 110-744
Contact: Jae W. Kim    011-82-760-2384      
Principal Investigator: Jae W. Kim         
Ewha Woman's University Active, not recruiting
Seoul, Korea, Republic of, 158-710
Gangnam Severance Hospital Recruiting
Seoul, Korea, Republic of, 135-720
Contact: Jae-Hoon Kim       clinical.trial@bms.com   
Principal Investigator: Jae-Hoon Kim         
Asan Medical Center Active, not recruiting
Seoul, Korea, Republic of, 138-736
Ajou University Hospital Recruiting
Suwon, Korea, Republic of, 443-721
Contact: Hee-Sug Ryu    031 219-4311~2      
Principal Investigator: Hee-Sug Ryu         
Sponsors and Collaborators
Investigators
Principal Investigator: Robert Coleman Gynecologic Oncology Group
  More Information

No publications provided

Responsible Party: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00565851     History of Changes
Other Study ID Numbers: NCI-2009-00587, NCI-2009-00587, CDR0000546714, GOG-0213, GOG-0213, U10CA027469
Study First Received: November 29, 2007
Last Updated: July 1, 2014
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Adenocarcinoma
Brenner Tumor
Carcinoma
Cystadenocarcinoma
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Carcinoma, Endometrioid
Cystadenocarcinoma, Mucinous
Cystadenocarcinoma, Serous
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Fibroepithelial
Neoplasms, Fibrous Tissue
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Gonadal Disorders
Endocrine System Diseases
Neoplasms, Cystic, Mucinous, and Serous
Abdominal Neoplasms
Neoplasms by Site
Digestive System Neoplasms
Digestive System Diseases
Peritoneal Diseases

ClinicalTrials.gov processed this record on July 26, 2014